Metformin in COVID-19: clinical trials are needed to prove its benefits.
作者信息
Kow Chia Siang, Ramachandram Dinesh Sangarran, Hasan Syed Shahzad
机构信息
School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.
School of Pharmacy, Monash University Malaysia, Bandar Sunway, Subang Jaya, Selangor, Malaysia.
出版信息
Ir J Med Sci. 2022 Dec;191(6):2641-2642. doi: 10.1007/s11845-021-02869-9. Epub 2022 Jan 8.
Abstract
摘要
相似文献
1
Metformin in COVID-19: clinical trials are needed to prove its benefits.
Ir J Med Sci. 2022 Dec;191(6):2641-2642. doi: 10.1007/s11845-021-02869-9. Epub 2022 Jan 8.
2
Response to "Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study".
Acta Diabetol. 2022 Jun;59(6):869-870. doi: 10.1007/s00592-022-01861-8. Epub 2022 Mar 4.
3
Is metformin a miracle or a menace in COVID-19 patients with type 2 diabetes?
J Diabetes Investig. 2021 Apr;12(4):479-481. doi: 10.1111/jdi.13484. Epub 2021 Jan 18.
4
WITHDRAWN: Metformin monotherapy for type 2 diabetes mellitus.
Cochrane Database Syst Rev. 2015 Sep 30(9):CD002966. doi: 10.1002/14651858.CD002966.pub4.
5
Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?
Diabetes Metab. 2021 Jul;47(4):101208. doi: 10.1016/j.diabet.2020.10.006. Epub 2020 Nov 4.
6
Comments on "Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials".
Diabetes Res Clin Pract. 2015 Apr;108(1):e1-2. doi: 10.1016/j.diabres.2015.02.004. Epub 2015 Feb 21.
7
Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study.
Life Sci. 2021 Jun 15;275:119371. doi: 10.1016/j.lfs.2021.119371. Epub 2021 Mar 19.
8
Metformin: are potential benefits on cancer risk extended to cancer survival?
Oncologist. 2013;18(12):1245-7. doi: 10.1634/theoncologist.2013-0381. Epub 2013 Nov 20.
9
[Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].
Pharm Unserer Zeit. 2002;31(3):264-70. doi: 10.1002/1615-1003(200205)31:3<264::AID-PAUZ264>3.0.CO;2-D.
10
Pioglitazone/metformin (Actoplus met).
Med Lett Drugs Ther. 2006 Jan 30;48(1227):9-11.
本文引用的文献
1
Metformin Use Is Associated with Decreased Mortality in COVID-19 Patients with Diabetes: Evidence from Retrospective Studies and Biological Mechanism.
J Clin Med. 2021 Aug 9;10(16):3507. doi: 10.3390/jcm10163507.
2
Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19.
Am J Ther. 2021 Aug 6;28(5):e616-e619. doi: 10.1097/MJT.0000000000001441.
3
The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis.
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2177-2183. doi: 10.1016/j.dsx.2020.11.006. Epub 2020 Nov 11.
4
Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis.
J Med Virol. 2021 Feb;93(2):695-697. doi: 10.1002/jmv.26498. Epub 2020 Sep 30.
5
Metformin use amid coronavirus disease 2019 pandemic.
J Med Virol. 2020 Nov;92(11):2401-2402. doi: 10.1002/jmv.26090. Epub 2020 Jun 9.
6
Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies.
Crit Care. 2019 Feb 18;23(1):50. doi: 10.1186/s13054-019-2346-4.
Zotero 插件